论文部分内容阅读
目的观察布地奈德雾化吸入治疗儿童哮喘急性发作的临床效果。方法选择2008年8月—2011年8月76例患有哮喘急性发作的患儿随机分为对照组和治疗组,对照组给予口服茶碱缓释片,治疗组雾化吸入布地奈德。结果总有效率、复发率对照组分别为81.6%、26.3%,治疗组分别为94.8%、10.5%,两组比较差异均有统计学意义(均P<0.05)。在治疗过程中,两组均无严重的并发症和不良反应。结论布地奈德雾化吸入对患有哮喘急性发作的患儿进行治疗效果明显,值得临床应用。
Objective To observe the clinical effect of inhalation of budesonide in the treatment of acute asthma in children. Methods From August 2008 to August 2011, 76 children with acute exacerbation of asthma were randomly divided into control group and treatment group. The control group was given oral theophylline sustained-release tablets, and the treatment group was inhaled budesonide. Results The total effective rate and recurrence rate were 81.6% and 26.3% in the control group and 94.8% and 10.5% in the treatment group, respectively (all P <0.05). In the course of treatment, no serious complications and adverse reactions were observed in both groups. Conclusions Budesonide inhalation is effective in the treatment of children with acute asthma attack, which is worthy of clinical application.